CMPS

COMPASS Pathways Plc Sponsored ADR · NASDAQ

Sector Health Technology
Industry Biotechnology
Website compasspathways.com
Employees(FY) 181
ISIN US20451W1018

Performance

-7.72%

-27.07%

-33.9%

-40.56%

-46.74%

YTD

-22.98%

Profile

COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. COMPASS Pathways plc was incorporated in 2020 and is headquartered in London, the United Kingdom.

Advanced Technical Analysis

Technical Analysis of CMPS 2024-11-20

The stock indicators reflect a predominantly bearish sentiment, with a Moving Average Score of 10 indicating strong downward momentum, an Oscillators Score of 40 suggesting a neutral stance, and a Technical Score of 25 reinforcing the overall bearish outlook. This combination signals caution for potential investors as the market appears to be st...

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of CMPS

Stock Rank

Recent News & Updates

2024-11-13 18:44
Compass Pathways to participate in Stifel 2024 Healthcare Conference(Globenewswire)
2024-11-01 21:25
Compass Pathways cuts 30% of workforce on Phase 3 trial delays(Yahoo Finance)
2024-10-31 23:00
Compass Pathways PLC (CMPS) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges ...(Yahoo Finance)
2024-10-31 09:00
Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript(Yahoo Finance)
2024-10-30 20:03
Compass delays anticipated psilocybin readout, cuts staff(Yahoo Finance)
2024-10-30 18:30
Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates(Businesswire)
2024-10-23 18:30
Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024(Businesswire)
2024-09-23 07:00
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit(Business Wire)
2024-09-22 19:00
Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit(Businesswire)
2024-08-28 06:00
Compass Pathways to participate in three investor conferences in September(GlobeNewswire)
2024-08-27 18:00
Compass Pathways to participate in three investor conferences in September(Globenewswire)
2024-08-25 09:06
Morgan Stanley Predicts up to 220% Jump for These 2 ‘Strong Buy’ Stocks(TipRanks)
2024-08-19 07:13
More promise for psilocybin in depression but safety remains a concern(Clinical Trials Arena)
2024-08-12 12:47
FDA Rejection of MDMA Therapy Isn’t End of Psychedelic-Drug Candidates(Barrons.com)
2024-08-06 08:00
COMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth Conference(GlobeNewswire)
2024-08-05 20:00
COMPASS Pathways to participate in Canaccord Genuity 44th Annual Growth Conference(Globenewswire)
2024-08-01 23:30
Compass Pathways Plc (CMPS) Q2 2024 Earnings Call Transcript(Motley Fool)
2024-08-01 06:30
Compass Pathways announces second quarter 2024 financial results and business highlights(GlobeNewswire)
2024-07-31 18:30
Compass Pathways announces second quarter 2024 financial results and business highlights(Globenewswire)
2024-07-28 18:05
Weekly Roundup on the Cannabis Sector & Psychedelic Sector(Market Exclusive)
2024-07-24 07:01
Compass Pathways to announce second quarter financial results on August 1, 2024(GlobeNewswire)
2024-07-23 19:01
Compass Pathways to announce second quarter financial results on August 1, 2024(Globenewswire)
2024-07-10 19:00
3 Dirt-Cheap Drug Developers With Blockbuster Potential(Investorplace)
2024-07-08 07:45
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers(InvestorPlace)
2024-07-07 19:45
3 Next-Gen Drug Stocks Exploring Psychedelic Frontiers(Investorplace)
2024-07-02 15:43
3 Psychedelic Stocks to Buy on the Dip: Summer 2024(InvestorPlace)
2024-07-02 03:43
3 Psychedelic Stocks to Buy on the Dip: Summer 2024(Investorplace)
2024-06-26 06:30
Compass Pathways appoints Lori Englebert as Chief Commercial Officer(GlobeNewswire)
2024-06-25 18:30
Compass Pathways appoints Lori Englebert as Chief Commercial Officer(Globenewswire)
2024-06-24 16:01
Compass Pathways to participate in upcoming H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference(GlobeNewswire)

Page 1 of 7

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.